EMEA-001782-PIP01-15-M03 - paediatric investigation plan
Influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains: A/(H1N1), A/(H3N2), B/Yamagata lineage, B/Victoria lineage
PIPHuman
Abbott Biologicals B.V.
Tel. +41 6148 70374
Email: hind.ounis@abbott.com
P/0211/2018: EMA decision of 17 July 2018 on the acceptance of a modification of an agreed paediatric investigation plan for influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains: A/(H1N1), A/(H3N2), B/Yamagata linea